Enhancing Alzheimer’s research participation among Asian Americans and Latinx communities.
Official title: Improving Inclusivity of Alzheimer’s Disease and Related Dementias Research for Asian Americans and Latinx through Nationally Representative Hybrid Sampling.
Funded at University of Michigan at Ann Arbor · NIH-11060885 · Data updated 2026-11-12
This study is working to include more Asian American and Latinx individuals in research about Alzheimer’s and related conditions, using a friendly approach to connect with people in these communities so their voices can help improve understanding and treatment of these diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | April 1, 2024 |
| Project end | March 21, 2025 |
| Funding year | 2025 |
| Award (this year) | $1,072,668 |
| NIH project number | 5R01AG082080-02 |
| Project ID | NIH-11060885 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are middle-aged and older adults from Asian American and Latinx backgrounds, particularly those from Afro Latinx, Chinese, Asian Indian, Filipino, Korean, and Vietnamese communities.
✕Less likely to help
Patients who do not belong to the targeted minority groups or are younger than 50 years old may not benefit from this research.
What this research studies
This research aims to improve the representation of Asian American and Latinx populations in Alzheimer’s Disease and Related Dementias (ADRD) research. It utilizes a novel Hybrid Sampling approach to create a nationally representative panel of middle-aged and older adults, focusing on seven specific minority groups. By employing a push-to-Web method, the study seeks to engage participants through their social networks, ensuring that those who are often hard to reach can contribute to important research data. This inclusive approach is designed to address existing health disparities in ADRD understanding and treatment.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for Alzheimer’s and related dementias in diverse populations.
How similar studies have gone: Previous research has shown that inclusive sampling methods can successfully engage underrepresented populations in health studies, indicating potential for success in this approach.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Lee, Sung-Hee — University of Michigan at Ann Arbor
- Study coordinator: Lee, Sung-Hee
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.